The insulin sensitivity advantage for tirzepatide is larger than weight loss alone explains (Diabetes, Obesity and Metabolism, 2025), which suggests the GIP component does real metabolic work beyond appetite suppression
This means there are 2,676 pending lawsuits in the federal litigation against Novo Nordisk and other GLP-1 manufacturers
What to expect: Up to 22% total body weight loss (based on Achieve member results and clinical studies) Major health improvements: reduced risk of diabetes, heart disease, fatty liver Confidence boost from clothes fitting better to improved self-image Long-term habits begin to stick, making this more than just a diet Achieve tip: Regular follow-up with your health coach ensures that weight loss is healthy, sustainable, and customized for your needs
00:00:11 Narrator On this episode, Associate Editor and Clinical Pharmacist Vickie Danaher reviews how the new oral version of semaglutide is changing how clinicians think about GLP1 medications for weight loss
Yes, the dosage and frequency of B12 injections are highly dependent on the severity of the deficiency and the presence of neurological symptoms
Apply gentle pressure with a cotton ball or gauze for 10 to 20 seconds